Firstpost
  • Home
  • Video Shows
    Vantage Firstpost America Firstpost Africa First Sports
  • World
    US News
  • Explainers
  • News
    India Opinion Cricket Tech Entertainment Sports Health Photostories
  • Asia Cup 2025
Apple Incorporated Modi ji Justin Trudeau Trending

Sections

  • Home
  • Live TV
  • Videos
  • Shows
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Health
  • Tech/Auto
  • Entertainment
  • Web Stories
  • Business
  • Impact Shorts

Shows

  • Vantage
  • Firstpost America
  • Firstpost Africa
  • First Sports
  • Fast and Factual
  • Between The Lines
  • Flashback
  • Live TV

Events

  • Raisina Dialogue
  • Independence Day
  • Champions Trophy
  • Delhi Elections 2025
  • Budget 2025
  • US Elections 2024
  • Firstpost Defence Summit
Trending:
  • PM Modi in Manipur
  • Charlie Kirk killer
  • Sushila Karki
  • IND vs PAK
  • India-US ties
  • New human organ
  • Downton Abbey: The Grand Finale Movie Review
fp-logo
Vantage | A diabetes drug Ozempic is going viral for the wrong reasons and that's a problem
Whatsapp Facebook Twitter
Whatsapp Facebook Twitter
Apple Incorporated Modi ji Justin Trudeau Trending

Sections

  • Home
  • Live TV
  • Videos
  • Shows
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Health
  • Tech/Auto
  • Entertainment
  • Web Stories
  • Business
  • Impact Shorts

Shows

  • Vantage
  • Firstpost America
  • Firstpost Africa
  • First Sports
  • Fast and Factual
  • Between The Lines
  • Flashback
  • Live TV

Events

  • Raisina Dialogue
  • Independence Day
  • Champions Trophy
  • Delhi Elections 2025
  • Budget 2025
  • US Elections 2024
  • Firstpost Defence Summit
  • Home
  • Opinion
  • Vantage | A diabetes drug Ozempic is going viral for the wrong reasons and that's a problem

Vantage | A diabetes drug Ozempic is going viral for the wrong reasons and that's a problem

The Vantage Take • November 16, 2023, 15:42:44 IST
Whatsapp Facebook Twitter

As the battle between vanity and common sense rages on, Ozempic remains at the centre, feeding off our insecurities and challenging the very essence of what it means to be healthy

Advertisement
Subscribe Join Us
Add as a preferred source on Google
Prefer
Firstpost
On
Google
Vantage | A diabetes drug Ozempic is going viral for the wrong reasons and that's a problem

In a world obsessed with body image and the pursuit of the perfect physique, a new player has entered the scene – Ozempic. Originally designed as a weekly injection to treat diabetes by lowering blood sugar levels, Ozempic has become the go-to elixir for those yearning for a future without fat.

The year 2023 has marked a milestone for Ozempic, earning the title of a miracle drug. From celebrities to ordinary individuals, its use has spread like wildfire, positioning it as a key player in the quest for the perfect body. Evolution of body ideals Over the past decade, societal standards of the perfect female body have been heavily influenced by a godless alliance between Instagram, TikTok and the Kardashians. Ozempic has emerged as a solution for those who haven’t been blessed with miracle genes, promising a future free from the shackles of excess weight. Notable personalities such as comedians Amy Schumer and Rosie O’Donnell, model and TikTok creator Remi Bader, NBA star Charles Barkley and even billionaire Elon Musk have openly admitted to using Ozempic. The trend is not limited to them, with other celebrities, including reality stars Khloe Kardashian and Kaeel Richards, are rumoured to be part of the Ozempic club. The Barbie dilemma For generations, the societal ideal of a woman’s appearance has been shaped by the plastic doll – Barbie. However, the pursuit of the perfect body has led many women down a path of self-loathing. Despite some progress, the pressure to conform to the thin ideal persists, affecting women of all shapes, sizes and backgrounds. The use of Ozempic has become so commonplace that it could soon be included in company-sponsored health plans in the US. This development could be a significant incentive for women in the workforce, potentially influencing career choices. While the road to achieving the Barbie-like figure has never been cheap, Ozempic and similar obesity drugs add a financial burden, costing upwards of $900 a month. Currently, less than half of large employers cover these drugs, but with around 18 per cent of big firms considering their inclusion, this may soon change. Ozempic has transcended personal choices and is making its mark as a corporate benefit. Similar to gym memberships in the past, Ozempic is now offered as part of employment packages, reflecting the unprecedented interest in this weight-loss drug. Pill version For those wary of injections, a pill version of Ozempic is on the horizon. This development could potentially make the drug more accessible, but it doesn’t come without its drawbacks. Dark side of Ozempic Despite its popularity, the Ozempic craze overlooks some serious pitfalls. A sudden surge in demand has led to a shortage of the drug originally intended for diabetic patients. Moreover, Ozempic comes with a laundry list of side effects, ranging from abdominal pain to an increase in heart rate. The fixation on looking “Insta-good” may be causing serious harm to health, as the pursuit of thinness clashes with common sense. As the battle between vanity and common sense rages on, Ozempic remains at the centre, feeding off our insecurities and challenging the very essence of what it means to be healthy. Views expressed in the above piece are personal and solely that of the author. They do not necessarily reflect Firstpost’s views. Read all the Latest News , Trending News , Cricket News , Bollywood News , India News and Entertainment News here. Follow us on Facebook, Twitter and Instagram.

Tags
Elon Musk Diabetes Khloe Kardashian Barbie Doll Amy Schumer Rosie O'Donnell Charles Barkley Ozempic Remi Bader Kaeel Richards
End of Article
Latest News
Find us on YouTube
Subscribe
End of Article

Impact Shorts

How army remains Pakistan’s biggest business house

How army remains Pakistan’s biggest business house

More Impact Shorts

Top Stories

Russian drones over Poland: Trump’s tepid reaction a wake-up call for Nato?

Russian drones over Poland: Trump’s tepid reaction a wake-up call for Nato?

As Russia pushes east, Ukraine faces mounting pressure to defend its heartland

As Russia pushes east, Ukraine faces mounting pressure to defend its heartland

Why Mossad was not on board with Israel’s strike on Hamas in Qatar

Why Mossad was not on board with Israel’s strike on Hamas in Qatar

Turkey: Erdogan's police arrest opposition mayor Hasan Mutlu, dozens officials in corruption probe

Turkey: Erdogan's police arrest opposition mayor Hasan Mutlu, dozens officials in corruption probe

Russian drones over Poland: Trump’s tepid reaction a wake-up call for Nato?

Russian drones over Poland: Trump’s tepid reaction a wake-up call for Nato?

As Russia pushes east, Ukraine faces mounting pressure to defend its heartland

As Russia pushes east, Ukraine faces mounting pressure to defend its heartland

Why Mossad was not on board with Israel’s strike on Hamas in Qatar

Why Mossad was not on board with Israel’s strike on Hamas in Qatar

Turkey: Erdogan's police arrest opposition mayor Hasan Mutlu, dozens officials in corruption probe

Turkey: Erdogan's police arrest opposition mayor Hasan Mutlu, dozens officials in corruption probe

Top Shows

Vantage Firstpost America Firstpost Africa First Sports
Latest News About Firstpost
Most Searched Categories
  • Web Stories
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Tech/Auto
  • Entertainment
  • IPL 2025
NETWORK18 SITES
  • News18
  • Money Control
  • CNBC TV18
  • Forbes India
  • Advertise with us
  • Sitemap
Firstpost Logo

is on YouTube

Subscribe Now

Copyright @ 2024. Firstpost - All Rights Reserved

About Us Contact Us Privacy Policy Cookie Policy Terms Of Use
Home Video Shorts Live TV